 and was actually associated with
increased morbidity compared with medical management.
Stenoses of ⬍60% diameter reduction were excluded from
the asymptomatic studies,5,6 assuming that asymptomatic
patients with stenosis ⬍60% would not benefit from carotid
reconstruction. Given the findings of the symptomatic trials, this proved to be an appropriate decision. There have
been no studies supporting either CEA or CAS for this
cohort